Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

7 C 11

Next Previous
Drug Profile

7 C 11

Alternative Names: 7-C-11; 7C11.e8

Latest Information Update: 21 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mass General Brigham
  • Developer Epoch Biotech; Mass General Brigham; National Cancer Institute (USA)
  • Class Antidementias; Antineoplastics; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Apolipoprotein E agonists; Complement activation stimulants; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Alzheimer's disease
  • Discontinued Malignant melanoma

Most Recent Events

  • 21 Jul 2026 Discontinued - Preclinical for Malignant melanoma in USA (Parenteral)
  • 15 Jul 2026 Preclinical trials in Alzheimer's disease in USA (Parenteral), prior to July 2026
  • 15 Jul 2026 Pharmacokinetics, pharmacodynamics, adverse events data from preclinical trials in Alzheimer's disease released by Epoch Biotech

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top